Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Effector Therapeutics Inc (EFTR)

Effector Therapeutics Inc (EFTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Effector Therapeutics Inc 142 North Cedros Avenue Suite B Solana Beach CA 92075 USA

effector.com P: 858-925-8215

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

eFFECTOR Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as STRIs. eFFECTOR Therapeutics Inc., formerly known as Locust Walk Acquisition Corp., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 1
Enterprise Value, $K 4,511
Shares Outstanding, K 4,704
Float, K 4,483
% Float 95.30%
Short Interest, K 57
Short Float 1.22%
Days to Cover 3.69
Short Volume Ratio 0.73
% of Insider Shareholders 4.70%
% of Institutional Shareholders 57.67%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -35,810 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,830 K
EBIT, $ -32,720 K
EBITDA, $ -33,080 K

Growth:

1-Year Return 0.00%
3-Year Return -100.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 07/03/25
Earnings Per Share ttm -13.08
EPS Growth vs. Prev Year -39.16%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 01/12/24

EFTR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 22.80
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.00
Book Value/Share 0.21
Interest Coverage -11.26
60-Month Beta 0.98
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar